Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Feng, Dan  [Clear All Filters]
2012
Nadeau S, An W, Palermo N, Feng D, Ahmad G, Dong L, Borgstahl GEO, Natarajan A, Naramura M, Band V, et al. Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins. Biochem Anal Biochem. 2012;Suppl 6(1).
2015
Huang L, Ma W, Ma Y, Feng D, Chen H, Cai B. Exosomes in Mesenchymal Stem Cells, a New Therapeutic Strategy for Cardiovascular Diseases?. Int J Biol Sci. 2015;11(2):238-245.
William BM, An W, Feng D, Nadeau S, Mohapatra BC, Storck MA, Band V, Band H. Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders. Hematology. 2015.
An W, Nadeau SA, Mohapatra BC, Feng D, Zutshi N, Storck MD, Arya P, Talmadge JE, Meza JL, Band V, et al. Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy. Oncotarget. 2015.
2016
Wei Z-R, Liang C, Feng D, Cheng Y-J, Wang W-M, Yang D-J, Wang Y-X, Cai Q-P. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer. Oncotarget. 2016.
2023
Zi Y, Liu L, Gao J, Xu X, Guan Y, Rong Z, Cao Z, Li M, Zeng Z, Fan Q, et al. Phosphorylation of PPDPF via IL6-JAK2 activates the Wnt/β-catenin pathway in colorectal cancer. EMBO Rep. 2023:e55060.
2024
Cao Y, Wang M, Wang F, Guo W, Ma Y, Li X, He Y, Pang A, Zhang R, Zhai W, et al. Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study. Chin Med J (Engl). 2024.